FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2346475797> ?p ?o ?g. }

• W2346475797 abstract "Survivin is a member of the inhibitor-of-apoptosis proteins family. It is overexpressed in many different cancer types but not in the differentiated normal tissue. In addition, overexpression of survivin promotes cancer cell survival and induces chemotherapeutic drug resistance, making it an attractive target for new anticancer interventions. Despite survivin being a promising molecular target for anticancer treatment, it is widely accepted that survivin is only a semi-druggable target. Therefore, it is important to develop a new strategy to target survivin for anticancer treatment. In this study, we constructed a novel survivin promoter-driven full-length antisense survivin (pSur/AS-Sur) expression plasmid DNA. Promoter activity assay revealed that the activity of the survivin promoter of pSur/AS-Sur correlated with the endogenous expression of survivin at the transcriptional level in the transfected A549, MDA-MB-231, and PANC-1 cancer cells. Western blot analysis showed that liposomal delivery of pSur/AS-Sur successfully downregulated the expression of survivin in A549, MBA-MB-231, and PANC-1 cells in vitro. In addition, delivery of pSur/AS-Sur induced autophagy, caspase-dependent apoptosis, and caspase-independent apoptosis as indicated by the increased LC3B-II conversion, autophagosome formation, caspase-9/-3 and poly(ADP-ribose) polymerase-1 cleavage, and apoptosis-inducing factor nuclear translocation in A549, MBA-MB-231, and PANC-1 cells. Importantly, liposomal delivery of pSur/AS-Sur was also capable of decreasing the proliferation of the survivin/MDR1 coexpressing multidrug-resistant KB-TAX50 cancer cells and the estrogen receptor-positive tamoxifen-resistant MCF7-TamC3 cancer cells in vitro. In conclusion, the results of this study suggest that delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA is a promising way to target survivin and to treat survivin-expressing cancers in the future." @default.
• W2346475797 created "2016-06-24" @default.
• W2346475797 creator A5007924986 @default.
• W2346475797 creator A5011414516 @default.
• W2346475797 creator A5019872641 @default.
• W2346475797 creator A5022182752 @default.
• W2346475797 creator A5062814872 @default.
• W2346475797 creator A5067555231 @default.
• W2346475797 date "2016-05-01" @default.
• W2346475797 modified "2023-09-24" @default.
• W2346475797 title "Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study" @default.
• W2346475797 cites W1506007624 @default.
• W2346475797 cites W1775749144 @default.
• W2346475797 cites W1909521595 @default.
• W2346475797 cites W1975494806 @default.
• W2346475797 cites W1979352058 @default.
• W2346475797 cites W1985003726 @default.
• W2346475797 cites W1996031072 @default.
• W2346475797 cites W1996667997 @default.
• W2346475797 cites W1999605095 @default.
• W2346475797 cites W2000493107 @default.
• W2346475797 cites W2006967327 @default.
• W2346475797 cites W2015262863 @default.
• W2346475797 cites W2019530589 @default.
• W2346475797 cites W2035523654 @default.
• W2346475797 cites W2036981368 @default.
• W2346475797 cites W2041710207 @default.
• W2346475797 cites W2044545697 @default.
• W2346475797 cites W2051025382 @default.
• W2346475797 cites W2053219638 @default.
• W2346475797 cites W2056772301 @default.
• W2346475797 cites W2060407805 @default.
• W2346475797 cites W2060725618 @default.
• W2346475797 cites W2072757049 @default.
• W2346475797 cites W2082353425 @default.
• W2346475797 cites W2086112151 @default.
• W2346475797 cites W2098816850 @default.
• W2346475797 cites W2103629572 @default.
• W2346475797 cites W2105035331 @default.
• W2346475797 cites W2127594372 @default.
• W2346475797 cites W2134877501 @default.
• W2346475797 cites W2135566609 @default.
• W2346475797 cites W2137809122 @default.
• W2346475797 cites W2139281532 @default.
• W2346475797 cites W2141531002 @default.
• W2346475797 cites W2149275138 @default.
• W2346475797 cites W2151559423 @default.
• W2346475797 cites W2153629484 @default.
• W2346475797 cites W2168042612 @default.
• W2346475797 cites W2168822330 @default.
• W2346475797 cites W2170785948 @default.
• W2346475797 cites W2321371720 @default.
• W2346475797 doi "https://doi.org/10.2147/ott.s101209" @default.
• W2346475797 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4862386" @default.
• W2346475797 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27217778" @default.
• W2346475797 hasPublicationYear "2016" @default.
• W2346475797 type Work @default.
• W2346475797 sameAs 2346475797 @default.
• W2346475797 citedByCount "5" @default.
• W2346475797 countsByYear W23464757972017 @default.
• W2346475797 countsByYear W23464757972018 @default.
• W2346475797 countsByYear W23464757972020 @default.
• W2346475797 countsByYear W23464757972022 @default.
• W2346475797 countsByYear W23464757972023 @default.
• W2346475797 crossrefType "journal-article" @default.
• W2346475797 hasAuthorship W2346475797A5007924986 @default.
• W2346475797 hasAuthorship W2346475797A5011414516 @default.
• W2346475797 hasAuthorship W2346475797A5019872641 @default.
• W2346475797 hasAuthorship W2346475797A5022182752 @default.
• W2346475797 hasAuthorship W2346475797A5062814872 @default.
• W2346475797 hasAuthorship W2346475797A5067555231 @default.
• W2346475797 hasBestOaLocation W23464757971 @default.
• W2346475797 hasConcept C121608353 @default.
• W2346475797 hasConcept C153911025 @default.
• W2346475797 hasConcept C185592680 @default.
• W2346475797 hasConcept C190283241 @default.
• W2346475797 hasConcept C2775975398 @default.
• W2346475797 hasConcept C502942594 @default.
• W2346475797 hasConcept C54009773 @default.
• W2346475797 hasConcept C54355233 @default.
• W2346475797 hasConcept C55493867 @default.
• W2346475797 hasConcept C81885089 @default.
• W2346475797 hasConcept C86803240 @default.
• W2346475797 hasConcept C96232424 @default.
• W2346475797 hasConceptScore W2346475797C121608353 @default.
• W2346475797 hasConceptScore W2346475797C153911025 @default.
• W2346475797 hasConceptScore W2346475797C185592680 @default.
• W2346475797 hasConceptScore W2346475797C190283241 @default.
• W2346475797 hasConceptScore W2346475797C2775975398 @default.
• W2346475797 hasConceptScore W2346475797C502942594 @default.
• W2346475797 hasConceptScore W2346475797C54009773 @default.
• W2346475797 hasConceptScore W2346475797C54355233 @default.
• W2346475797 hasConceptScore W2346475797C55493867 @default.
• W2346475797 hasConceptScore W2346475797C81885089 @default.
• W2346475797 hasConceptScore W2346475797C86803240 @default.
• W2346475797 hasConceptScore W2346475797C96232424 @default.
• W2346475797 hasLocation W23464757971 @default.
• W2346475797 hasLocation W23464757972 @default.
• W2346475797 hasLocation W23464757973 @default.
• W2346475797 hasLocation W23464757974 @default.

• next